ARK Genomic Revolution ETF
ARKG
ARKG
386 hedge funds and large institutions have $1.09B invested in ARK Genomic Revolution ETF in 2022 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 113 increasing their positions, 159 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
386
Holders Change
-73
Holders Change %
-15.9%
% of All Funds
6.11%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
40
Increased
113
Reduced
159
Closed
110
Calls
$185M
Puts
$357M
Net Calls
-$171M
Net Calls Change
+$145M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$53.8M |
| 2 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$45.9M |
| 3 |
Morgan Stanley
New York
|
+$25.5M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$19.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$10.5M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$18.3M |
| 2 |
Jane Street
New York
|
-$13.3M |
| 3 |
JPMorgan Chase & Co
New York
|
-$10.1M |
| 4 |
CPA
Capital Planning Advisors
Roseville,
California
|
-$9.04M |
| 5 |
EP
Eversept Partners
New York
|
-$8.91M |
